News & Events
-
August 15, 2015
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
Pasipanodya JG, Nuermberger E, Romero K, Hanna D, Gumbo T. Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Aug 15;61 Suppl 1:S10–7.
-
August 15, 2015
Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes
Gumbo T, Pasipanodya JG, Romero K, Hanna D, Nuermberger E. Forecasting Accuracy of the Hollow Fiber Model of Tuberculosis for Clinical Therapeutic Outcomes. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Aug 15;61 Suppl 1:S25–31.
-
August 15, 2015
Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments
Pasipanodya JG, Nuermberger E, Romero K, Hanna D, Gumbo T. Systematic Analysis of Hollow Fiber Model of Tuberculosis Experiments. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Aug 15;61 Suppl 1:S10–7.
-
August 15, 2015
Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool
Romero K, Clay R, Hanna D. Strategic Regulatory Evaluation and Endorsement of the Hollow Fiber Tuberculosis System as a Novel Drug Development Tool. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America. 2015 Aug 15;61 Suppl 1:S5–9.
-
August 7, 2015
Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates
Offringa M, Davis JM, Turner MA, Ward R, Bax R, Maldonado S, Sinha V, McCune SK, Zajicek A, Daniel K. Benjamin J, Bucci-Rechtweg C, Nelson RM. Applying Regulatory Science to Develop Safe and Effective Medicines for Neonates. Therapeutic Innovation & Regulatory Science. 2015 Aug 7;